Executive summaries on hypertension II. Choices of initial drug therapy

Norman M Kaplan

doi:10.1358/dot.1998.34.1.485196

Executive summaries on hypertension II. Choices of initial drug therapy

Norman M Kaplan

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.

Original language	English (US)
Pages (from-to)	17-23
Number of pages	7
Journal	Drugs of Today
Volume	34
Issue number	1
DOIs	https://doi.org/10.1358/dot.1998.34.1.485196
State	Published - 1998

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1358/dot.1998.34.1.485196

Cite this

@article{3f41bb79225741debfefadb8e2de9c9b,

title = "Executive summaries on hypertension II. Choices of initial drug therapy",

abstract = "Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.",

author = "Kaplan, {Norman M}",

year = "1998",

doi = "10.1358/dot.1998.34.1.485196",

language = "English (US)",

volume = "34",

pages = "17--23",

journal = "Drugs of Today",

issn = "1699-3993",

publisher = "Prous Science",

number = "1",

}

TY - JOUR

T1 - Executive summaries on hypertension II. Choices of initial drug therapy

AU - Kaplan, Norman M

PY - 1998

Y1 - 1998

N2 - Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.

AB - Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.

UR - http://www.scopus.com/inward/record.url?scp=0031906286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031906286&partnerID=8YFLogxK

U2 - 10.1358/dot.1998.34.1.485196

DO - 10.1358/dot.1998.34.1.485196

M3 - Review article

C2 - 15094860

AN - SCOPUS:0031906286

SN - 1699-3993

VL - 34

SP - 17

EP - 23

JO - Drugs of Today

JF - Drugs of Today

IS - 1

ER -

Executive summaries on hypertension II. Choices of initial drug therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this